Charles Brandes acquired 1.91M MerckInc shares worth $161M. That's 1.41% of their equity portfolio (20th largest holding). The first MerckInc trade was made in Q1 2013. Since then Charles Brandes bought shares nineteen more times and sold shares on 30 occasions. The stake costed the investor $119M, netting the investor a gain of 35% so far.